A 2018 study has compared the intestinal microbiota in the feces of healthy individuals and NASH patients, finding that the hematopoietic cell marker differentiation cluster CD45+ and the KC marker CD163+ are higher in NAFLD (Schwenger et al., 2018). This evidence concerns the gene CALCA and metabolic dysfunction-associated steatotic liver disease.